Cytomegalovirus (CMV) Infection Causes Degeneration of Cochlear Vasculature and Hearing Loss in a Mouse Model.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27995350)

Published in J Assoc Res Otolaryngol on December 19, 2016

Authors

Mattia Carraro1,2, Ali Almishaal3, Elaine Hillas4, Matthew Firpo4, Albert Park4,5, Robert V Harrison6,7,8

Author Affiliations

1: Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada.
2: Auditory Science Laboratory, Neuroscience and Mental Health Program, The Hospital for Sick Children, Toronto, ON, Canada.
3: Department of Communication Sciences and Disorders, University of Utah, Salt Lake City, UT, USA.
4: Department of Surgery, University of Utah, Salt Lake City, UT, USA.
5: Department of Otolaryngology, University of Utah, Salt Lake City, UT, USA.
6: Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada. rvh@sickkids.ca.
7: Auditory Science Laboratory, Neuroscience and Mental Health Program, The Hospital for Sick Children, Toronto, ON, Canada. rvh@sickkids.ca.
8: Department of Otolaryngology, Head and Neck Surgery, University of Toronto, Toronto, ON, Canada. rvh@sickkids.ca.

Articles cited by this

NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41

Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med (2015) 3.75

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr (2003) 3.38

Equivalent ages in mouse and human embryos. Anat Rec (1954) 3.30

Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr (1997) 2.93

The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev (2013) 2.28

Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis (1991) 2.25

A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J Pediatr (2008) 1.90

Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol (2005) 1.90

Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr (1999) 1.78

Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development (1989) 1.72

In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature (1981) 1.71

Mechanisms of endocochlear potential generation by stria vascularis. Laryngoscope (1987) 1.66

Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol (2001) 1.65

Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol (2007) 1.65

Experiments on temporary obstruction of the internal auditory artery. Laryngoscope (1959) 1.60

The effects of furosemide on the endocochlear potential and auditory-nerve fiber tuning curves in cats. Hear Res (1984) 1.55

How is the highly positive endocochlear potential formed? The specific architecture of the stria vascularis and the roles of the ion-transport apparatus. Pflugers Arch (2009) 1.51

Lateral wall Na,K-ATPase and endocochlear potentials decline with age in quiet-reared gerbils. Hear Res (1992) 1.44

Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol (2005) 1.43

Connexin30 deficiency causes instrastrial fluid-blood barrier disruption within the cochlear stria vascularis. Proc Natl Acad Sci U S A (2007) 1.41

The influence of ischemia upon the energy reserves of inner ear tissues. Laryngoscope (1972) 1.35

Vaccines for the 21st century. EMBO Mol Med (2014) 1.17

Hearing loss and congenital CMV infection: a systematic review. Pediatrics (2014) 1.07

Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency. Exp Hematol (2006) 1.06

Resident macrophages in the cochlear blood-labyrinth barrier and their renewal via migration of bone-marrow-derived cells. Cell Tissue Res (2010) 1.03

Detection of cytomegalovirus DNA in dried blood spots of Minnesota infants who do not pass newborn hearing screening. Pediatr Infect Dis J (2009) 1.03

Cochlear potentials and oxygen associated with hypoxia. Ann Otol Rhinol Laryngol (1975) 1.00

Ion flow in stria vascularis and the production and regulation of cochlear endolymph and the endolymphatic potential. Hear Res (2011) 0.95

The nature and progression of injury in the organ of Corti during ischemia. Hear Res (1989) 0.93

Morphological patterns of angiogenesis in ovarian follicle capillary networks. A scanning electron microscopy study of corrosion cast. Microsc Res Tech (2006) 0.92

Endothelial cell, pericyte, and perivascular resident macrophage-type melanocyte interactions regulate cochlear intrastrial fluid-blood barrier permeability. J Assoc Res Otolaryngol (2012) 0.92

Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J Neurovirol (2011) 0.86

Murine CMV-induced hearing loss is associated with inner ear inflammation and loss of spiral ganglia neurons. PLoS Pathog (2015) 0.84

Differential vulnerability of inner and outer hair cell systems to chronic mild hypoxia and glutamate ototoxicity: insights into the cause of auditory neuropathy. J Otolaryngol (2001) 0.83

Congenital cytomegalovirus infection in pediatric hearing loss. Arch Otolaryngol Head Neck Surg (2011) 0.83

A comparison of different murine models for cytomegalovirus-induced sensorineural hearing loss. Laryngoscope (2013) 0.82

The effect of mannitol upon cochlear dysfunction induced by transient local anoxia. Hear Res (1998) 0.82

Induction of cytomegalovirus-infected labyrinthitis in newborn mice by lipopolysaccharide: a model for hearing loss in congenital CMV infection. Lab Invest (2008) 0.80

Hearing status in children with congenital cytomegalovirus: up-to-6-years audiological follow-up. Int J Pediatr Otorhinolaryngol (2011) 0.79

A diagnostic paradigm including cytomegalovirus testing for idiopathic pediatric sensorineural hearing loss. Laryngoscope (2014) 0.79

Intermediate endocochlear potential levels induced by hypoxia. Acta Otolaryngol (1977) 0.78

ABR threshold is a function of blood oxygen level. Hear Res (1989) 0.78

Hearing outcome of infants with congenital cytomegalovirus and hearing impairment. Arch Dis Child (2016) 0.77

Hearing thresholds in children with a congenital CMV infection: a prospective study. Int J Pediatr Otorhinolaryngol (2012) 0.77

Pathological changes of the inner ear cochlea in different time windows of murine cytomegalovirus-induced hearing loss in a mouse model. Acta Otolaryngol (2015) 0.76

Partial corrosion casting to assess cochlear vasculature in mouse models of presbycusis and CMV infection. Hear Res (2015) 0.76

Degeneration of stria vascularis in age-related hearing loss; a corrosion cast study in a mouse model. Acta Otolaryngol (2016) 0.76

Angiogenesis in costal cartilage graft laryngotracheoplasty: a corrosion casting study in piglets. Laryngoscope (2014) 0.76